Tyra biosciences reports fourth quarter and full year 2021 financial results and highlights

Carlsbad, calif., march 3, 2022 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today reported financial results for the quarter and year ended december 31, 2021 and highlighted recent corporate progress.
TYRA Ratings Summary
TYRA Quant Ranking